Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats

Detalhes bibliográficos
Autor(a) principal: Longhini, Renata [UNIFESP]
Data de Publicação: 2013
Outros Autores: Oliveira, Priscila Aparecida de [UNIFESP], Souza Faloni, Ana Paula de [UNIFESP], Sasso-Cerri, Estela [UNIFESP], Cerri, Paulo Sergio [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/35894
http://dx.doi.org/10.1111/joa.12011
Resumo: It has been demonstrated that histamine interferes with the recruitment, formation and activity of osteoclasts via H1- and H2-receptors. Cimetidine is a H2-receptor antagonist used for treatment of gastric ulcers that seems to prevent bone resorption. in this study, a possible cimetidine interference was investigated in the number of alveolar bone osteoclasts. the incidence of osteoclast apoptosis and immunoexpression of RANKL (receptor activator of nuclear factor ?B ligand) was also evaluated. Adult male rats were treated with 100 mg kg-1 of cimetidine for 50 days (CimG); the sham group (SG) received saline. Maxillary fragments containing the first molars and alveolar bone were fixed, decalcified and embedded in paraffin. the sections were stained by H&E or submitted to tartrate-resistant acid phosphatase (TRAP) method. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling) method and immunohistochemical reactions for detecting caspase-3 and RANKL were performed. the number of TRAP-positive osteoclasts, the frequency of apoptotic osteoclasts and the numerical density of RANKL-positive cells were obtained. Osteoclast death by apoptosis was confirmed by transmission electron microscopy (TEM). in CimG, TRAP-positive osteoclasts with TUNEL-positive nuclei and caspase-3-immunolabeled osteoclasts were found. A significant reduction in the number of TRAP-positive osteoclasts and a high frequency of apoptotic osteoclasts were observed in CimG. Under TEM, detached osteoclasts from the bone surface showed typical features of apoptosis. Moreover, a significant reduction in the numerical density of RANKL-positive cells was observed in CimG. the significant reduction in the number of osteoclasts may be due to cimetidine-induced osteoclast apoptosis. However, RANKL immunoexpression reduction also suggests a possible interference of cimetidine treatment in the osteoclastogenesis.
id UFSP_551f6a8edc91d995e67bbc37ed5c2bd0
oai_identifier_str oai:repositorio.unifesp.br:11600/35894
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Longhini, Renata [UNIFESP]Oliveira, Priscila Aparecida de [UNIFESP]Souza Faloni, Ana Paula de [UNIFESP]Sasso-Cerri, Estela [UNIFESP]Cerri, Paulo Sergio [UNIFESP]Universidade Federal de São Paulo (UNIFESP)Univ Estadual Paulista2016-01-24T14:31:09Z2016-01-24T14:31:09Z2013-02-01Journal of Anatomy. Hoboken: Wiley-Blackwell, v. 222, n. 2, p. 239-247, 2013.0021-8782http://repositorio.unifesp.br/handle/11600/35894http://dx.doi.org/10.1111/joa.1201110.1111/joa.12011WOS:000313806100009It has been demonstrated that histamine interferes with the recruitment, formation and activity of osteoclasts via H1- and H2-receptors. Cimetidine is a H2-receptor antagonist used for treatment of gastric ulcers that seems to prevent bone resorption. in this study, a possible cimetidine interference was investigated in the number of alveolar bone osteoclasts. the incidence of osteoclast apoptosis and immunoexpression of RANKL (receptor activator of nuclear factor ?B ligand) was also evaluated. Adult male rats were treated with 100 mg kg-1 of cimetidine for 50 days (CimG); the sham group (SG) received saline. Maxillary fragments containing the first molars and alveolar bone were fixed, decalcified and embedded in paraffin. the sections were stained by H&E or submitted to tartrate-resistant acid phosphatase (TRAP) method. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling) method and immunohistochemical reactions for detecting caspase-3 and RANKL were performed. the number of TRAP-positive osteoclasts, the frequency of apoptotic osteoclasts and the numerical density of RANKL-positive cells were obtained. Osteoclast death by apoptosis was confirmed by transmission electron microscopy (TEM). in CimG, TRAP-positive osteoclasts with TUNEL-positive nuclei and caspase-3-immunolabeled osteoclasts were found. A significant reduction in the number of TRAP-positive osteoclasts and a high frequency of apoptotic osteoclasts were observed in CimG. Under TEM, detached osteoclasts from the bone surface showed typical features of apoptosis. Moreover, a significant reduction in the numerical density of RANKL-positive cells was observed in CimG. the significant reduction in the number of osteoclasts may be due to cimetidine-induced osteoclast apoptosis. However, RANKL immunoexpression reduction also suggests a possible interference of cimetidine treatment in the osteoclastogenesis.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fed Univ São Paulo UNIFESP, Dept Morphol & Genet, São Paulo, BrazilUniv Estadual Paulista, UNESP, Sch Dent, Dept Morphol,Lab Histol & Embryol, BR-14801903 Araraquara, SP, BrazilFed Univ São Paulo UNIFESP, Dept Morphol & Genet, São Paulo, BrazilFAPESP: FAPESP - 2007/59374-6FAPESP: 2010/03571-0FAPESP: 2010/10391-9Web of Science239-247engWiley-BlackwellJournal of Anatomyhttp://olabout.wiley.com/WileyCDA/Section/id-406071.htmlinfo:eu-repo/semantics/openAccessalveolar boneapoptosiscimetidineosteoclastosteoclastogenesisIncreased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated ratsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlereponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/358942023-02-15 11:46:39.941metadata only accessoai:repositorio.unifesp.br:11600/35894Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-02-15T14:46:39Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
title Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
spellingShingle Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
Longhini, Renata [UNIFESP]
alveolar bone
apoptosis
cimetidine
osteoclast
osteoclastogenesis
title_short Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
title_full Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
title_fullStr Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
title_full_unstemmed Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
title_sort Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats
author Longhini, Renata [UNIFESP]
author_facet Longhini, Renata [UNIFESP]
Oliveira, Priscila Aparecida de [UNIFESP]
Souza Faloni, Ana Paula de [UNIFESP]
Sasso-Cerri, Estela [UNIFESP]
Cerri, Paulo Sergio [UNIFESP]
author_role author
author2 Oliveira, Priscila Aparecida de [UNIFESP]
Souza Faloni, Ana Paula de [UNIFESP]
Sasso-Cerri, Estela [UNIFESP]
Cerri, Paulo Sergio [UNIFESP]
author2_role author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Univ Estadual Paulista
dc.contributor.author.fl_str_mv Longhini, Renata [UNIFESP]
Oliveira, Priscila Aparecida de [UNIFESP]
Souza Faloni, Ana Paula de [UNIFESP]
Sasso-Cerri, Estela [UNIFESP]
Cerri, Paulo Sergio [UNIFESP]
dc.subject.eng.fl_str_mv alveolar bone
apoptosis
cimetidine
osteoclast
osteoclastogenesis
topic alveolar bone
apoptosis
cimetidine
osteoclast
osteoclastogenesis
description It has been demonstrated that histamine interferes with the recruitment, formation and activity of osteoclasts via H1- and H2-receptors. Cimetidine is a H2-receptor antagonist used for treatment of gastric ulcers that seems to prevent bone resorption. in this study, a possible cimetidine interference was investigated in the number of alveolar bone osteoclasts. the incidence of osteoclast apoptosis and immunoexpression of RANKL (receptor activator of nuclear factor ?B ligand) was also evaluated. Adult male rats were treated with 100 mg kg-1 of cimetidine for 50 days (CimG); the sham group (SG) received saline. Maxillary fragments containing the first molars and alveolar bone were fixed, decalcified and embedded in paraffin. the sections were stained by H&E or submitted to tartrate-resistant acid phosphatase (TRAP) method. TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling) method and immunohistochemical reactions for detecting caspase-3 and RANKL were performed. the number of TRAP-positive osteoclasts, the frequency of apoptotic osteoclasts and the numerical density of RANKL-positive cells were obtained. Osteoclast death by apoptosis was confirmed by transmission electron microscopy (TEM). in CimG, TRAP-positive osteoclasts with TUNEL-positive nuclei and caspase-3-immunolabeled osteoclasts were found. A significant reduction in the number of TRAP-positive osteoclasts and a high frequency of apoptotic osteoclasts were observed in CimG. Under TEM, detached osteoclasts from the bone surface showed typical features of apoptosis. Moreover, a significant reduction in the numerical density of RANKL-positive cells was observed in CimG. the significant reduction in the number of osteoclasts may be due to cimetidine-induced osteoclast apoptosis. However, RANKL immunoexpression reduction also suggests a possible interference of cimetidine treatment in the osteoclastogenesis.
publishDate 2013
dc.date.issued.fl_str_mv 2013-02-01
dc.date.accessioned.fl_str_mv 2016-01-24T14:31:09Z
dc.date.available.fl_str_mv 2016-01-24T14:31:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Journal of Anatomy. Hoboken: Wiley-Blackwell, v. 222, n. 2, p. 239-247, 2013.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/35894
http://dx.doi.org/10.1111/joa.12011
dc.identifier.issn.none.fl_str_mv 0021-8782
dc.identifier.doi.none.fl_str_mv 10.1111/joa.12011
dc.identifier.wos.none.fl_str_mv WOS:000313806100009
identifier_str_mv Journal of Anatomy. Hoboken: Wiley-Blackwell, v. 222, n. 2, p. 239-247, 2013.
0021-8782
10.1111/joa.12011
WOS:000313806100009
url http://repositorio.unifesp.br/handle/11600/35894
http://dx.doi.org/10.1111/joa.12011
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Journal of Anatomy
dc.rights.driver.fl_str_mv http://olabout.wiley.com/WileyCDA/Section/id-406071.html
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://olabout.wiley.com/WileyCDA/Section/id-406071.html
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 239-247
dc.publisher.none.fl_str_mv Wiley-Blackwell
publisher.none.fl_str_mv Wiley-Blackwell
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764199055589376